FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY

FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY

The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII; (2) PCC; and (3) a three factor combination of FH, FX and FVIIa. The clotting factor treatment can be administered in combination with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HANSSON KENNY, LOVGREN ANN
Format: Patent
Sprache:eng ; pol
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HANSSON KENNY
LOVGREN ANN
description The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII; (2) PCC; and (3) a three factor combination of FH, FX and FVIIa. The clotting factor treatment can be administered in combination with fibrinogen. The clotting factor(s) can be recombinant human clotting factor(s).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL2624859TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL2624859TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL2624859TT33</originalsourceid><addsrcrecordid>eNqNjU0KwjAQhbtxIeodxgO4aVV0OaaJGchPSaaIq1IkrkQL9Qge3FY9gKv3eHx8b5q9FAr2AYgAjXcSxu5AeHsgh0zewYlYg6oDaxngi0dQA8dBIlvpGLwCshVSkCVolNZHxkgRMEYvCHmYP5aSTD060QwPeKyNr5D1eZ5Nru2tT4tfzrKlkiz0KnWPJvVde0n39Gwqk2_z9W6zZy6Kf5g3co0-Ew</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY</title><source>esp@cenet</source><creator>HANSSON KENNY ; LOVGREN ANN</creator><creatorcontrib>HANSSON KENNY ; LOVGREN ANN</creatorcontrib><description>The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII; (2) PCC; and (3) a three factor combination of FH, FX and FVIIa. The clotting factor treatment can be administered in combination with fibrinogen. The clotting factor(s) can be recombinant human clotting factor(s).</description><language>eng ; pol</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170929&amp;DB=EPODOC&amp;CC=PL&amp;NR=2624859T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76553</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170929&amp;DB=EPODOC&amp;CC=PL&amp;NR=2624859T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HANSSON KENNY</creatorcontrib><creatorcontrib>LOVGREN ANN</creatorcontrib><title>FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY</title><description>The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII; (2) PCC; and (3) a three factor combination of FH, FX and FVIIa. The clotting factor treatment can be administered in combination with fibrinogen. The clotting factor(s) can be recombinant human clotting factor(s).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjU0KwjAQhbtxIeodxgO4aVV0OaaJGchPSaaIq1IkrkQL9Qge3FY9gKv3eHx8b5q9FAr2AYgAjXcSxu5AeHsgh0zewYlYg6oDaxngi0dQA8dBIlvpGLwCshVSkCVolNZHxkgRMEYvCHmYP5aSTD060QwPeKyNr5D1eZ5Nru2tT4tfzrKlkiz0KnWPJvVde0n39Gwqk2_z9W6zZy6Kf5g3co0-Ew</recordid><startdate>20170929</startdate><enddate>20170929</enddate><creator>HANSSON KENNY</creator><creator>LOVGREN ANN</creator><scope>EVB</scope></search><sort><creationdate>20170929</creationdate><title>FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY</title><author>HANSSON KENNY ; LOVGREN ANN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL2624859TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HANSSON KENNY</creatorcontrib><creatorcontrib>LOVGREN ANN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HANSSON KENNY</au><au>LOVGREN ANN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY</title><date>2017-09-29</date><risdate>2017</risdate><abstract>The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII; (2) PCC; and (3) a three factor combination of FH, FX and FVIIa. The clotting factor treatment can be administered in combination with fibrinogen. The clotting factor(s) can be recombinant human clotting factor(s).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; pol
recordid cdi_epo_espacenet_PL2624859TT3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-09T20%3A15%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HANSSON%20KENNY&rft.date=2017-09-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL2624859TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true